Goldman Sachs Cuts Price Target on United Therapeutics (UTHR), But Still Sees 30% Upside

Go back to Goldman Sachs Cuts Price Target on United Therapeutics (UTHR), But Still Sees 30% Upside
United Therapeutics Corp (NASDAQ: UTHR) Delayed: 521.00 -8.14 (1.54%)
Previous Close $529.14    52 Week High $164.04 
Open $524.15    52 Week Low $97.52 
Day High $529.26    P/E 95.25 
Day Low $517.88    EPS $5.47 
Volume 440,386